Scarica l'app Stockscreener
10.96
0.92%
0.10
Dopo l'orario di chiusura:
10.96
Precedente Chiudi:
$10.86
Aprire:
$10.89
Volume 24 ore:
367.96K
Relative Volume:
0.56
Capitalizzazione di mercato:
$234.30M
Reddito:
$66.59M
Utile/perdita netta:
$-104.93M
Rapporto P/E:
-2.2141
EPS:
-4.95
Flusso di cassa netto:
$-96.48M
1 W Prestazione:
+4.28%
1M Prestazione:
-8.44%
6M Prestazione:
+79.97%
1 anno Prestazione:
-2.53%
Intervallo 1D:
$10.62
$11.08
Intervallo di 1 settimana:
$10.30
$11.45
Portata 52W:
$4.09
$15.34
Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile
Nome
Enanta Pharmaceuticals Inc
Settore
Industria
Telefono
617 607 0800
Indirizzo
4 KINGSBURY AVENUE, WATERTOWN, MA
Confronta ENTA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ENTA
Enanta Pharmaceuticals Inc
|
10.96 | 313.34M | 66.59M | -104.93M | -96.48M | -4.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-01 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-07-28 | Ripresa | H.C. Wainwright | Buy |
| 2023-08-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-08-08 | Downgrade | Jefferies | Buy → Hold |
| 2022-12-09 | Iniziato | H.C. Wainwright | Buy |
| 2022-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-10-07 | Iniziato | Jefferies | Buy |
| 2021-09-09 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-01-29 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-11-24 | Iniziato | Evercore ISI | Underperform |
| 2020-08-28 | Ripresa | ROTH Capital | Buy |
| 2020-08-26 | Iniziato | Piper Sandler | Overweight |
| 2020-07-27 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2020-03-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-11-22 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-05-24 | Iniziato | Wolfe Research | Outperform |
| 2019-04-23 | Aggiornamento | Berenberg | Hold → Buy |
| 2018-12-13 | Iniziato | Berenberg | Hold |
| 2018-06-06 | Iniziato | ROTH Capital | Buy |
| 2018-02-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-01-02 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2017-11-21 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-07-11 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-04-28 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2016-02-09 | Reiterato | Barclays | Underweight |
| 2015-10-23 | Downgrade | Barclays | Equal Weight → Underweight |
| 2015-10-23 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
Mostra tutto
Enanta Pharmaceuticals Inc Borsa (ENTA) Ultime notizie
Tools to assess Enanta Pharmaceuticals Inc.’s risk profileMarket Risk Analysis & Accurate Entry and Exit Point Alerts - newser.com
Why Enanta Pharmaceuticals Inc. (9EP) stock gets analyst attentionQuarterly Market Summary & Weekly Chart Analysis and Guides - newser.com
How Enanta Pharmaceuticals Inc. stock compares to growth peersMarket Risk Summary & Weekly Momentum Stock Picks - newser.com
Why Enanta Pharmaceuticals Inc. stock is rated strong buyWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
How to forecast Enanta Pharmaceuticals Inc. trends using time seriesJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
Using Ichimoku Cloud for Enanta Pharmaceuticals Inc. technicalsStop Loss & Accurate Trade Setup Notifications - newser.com
Is Enanta Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Setups & AI Enhanced Trading Signals - newser.com
How Enanta Pharmaceuticals Inc. stock performs in rising dollar environmentWall Street Watch & Risk Adjusted Buy/Sell Alerts - newser.com
Is Enanta Pharmaceuticals Inc. stock a good choice for value investorsStock Surge & Stock Portfolio Risk Control - newser.com
How Enanta Pharmaceuticals Inc. stock benefits from strong dollar2025 Market Trends & Verified Entry Point Signals - newser.com
Can Enanta Pharmaceuticals Inc. (9EP) stock deliver strong annual returnsWeekly Market Report & Comprehensive Market Scan Reports - newser.com
Will breakout in Enanta Pharmaceuticals Inc. lead to full recoveryJuly 2025 Rallies & Stock Timing and Entry Methods - newser.com
Will earnings trigger a reversal in Enanta Pharmaceuticals Inc.2025 Big Picture & Daily Stock Trend Watchlist - newser.com
Is Enanta Pharmaceuticals Inc. stock positioned well for digital economyTrade Volume Summary & Fast Moving Market Watchlists - newser.com
How reliable is Enanta Pharmaceuticals Inc. (9EP) stock dividend growth2025 Analyst Calls & Technical Pattern Alert System - newser.com
What the charts say about Enanta Pharmaceuticals Inc. todayWeekly Profit Recap & Safe Entry Trade Reports - newser.com
What drives Enanta Pharmaceuticals Inc 9EP stock priceStraddle and Strangle Trades & Lower Drawdowns With Smart Position Sizing - earlytimes.in
Is Enanta Pharmaceuticals Inc. stock supported by strong cash flowsWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
How institutional buying supports Enanta Pharmaceuticals Inc. stockQuarterly Trade Report & Growth Focused Entry Reports - newser.com
Can Enanta Pharmaceuticals Inc. stock resist market sell offsDip Buying & Safe Swing Trade Setups - newser.com
Is Enanta Pharmaceuticals Inc. stock attractive for retirement portfoliosDay Trade & Stepwise Swing Trade Plans - newser.com
How to use a screener to detect Enanta Pharmaceuticals Inc. breakoutsWeekly Gains Report & Risk Controlled Stock Pick Alerts - newser.com
Trend analysis for Enanta Pharmaceuticals Inc. this weekJuly 2025 Catalysts & Smart Swing Trading Alerts - newser.com
How Enanta Pharmaceuticals Inc. stock compares to industry benchmarksWeekly Trade Review & Community Consensus Stock Picks - newser.com
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Not Doing Enough For Some Investors As Its Shares Slump 30% - simplywall.st
Enanta Pharmaceuticals Inc Azioni (ENTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):